MCL1 and cancer: Based on our earlier in silico and in vitro panel of experiments, we found that MOXI exhibits the ability to interact with the Mcl-1 protein as a common molecular target with BH3 mimetics and suggests the possibility of their synergistic mode of action towards cancer cells with elevated levels of Mcl-1 protein [10].